[6-K] ALTERITY THERAPEUTICS LTD C... | ATHE SEC Filing - Form 6-K

robot
Abstract generation in progress

Alterity Therapeutics Limited (ATHE) filed a Form 6-K with the SEC on March 26, 2026, which included a notification regarding unquoted securities. This report is incorporated by reference into several of their existing registration statements. The filing was signed by Julian Babarczy, Chairman of Alterity Therapeutics Limited.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin